Grants for Small businesses - Federal

This program provides funding for research institutions and organizations to develop advanced techniques for improving the performance and reliability of quantum computing systems, specifically targeting applications in national defense.

The National Science Foundation's Directorates for Engineering (ENG), Computer and Information Science and Engineering (CISE), Mathematical Physical Sciences (MPS), and Social, Behavioral and Economic Sciences (SBE) are coordinating efforts to create fundamental understanding that will enablecontinued effective use of an essential common resource, the electromagnetic spectrum. Existing approaches to spectrum management and regulationhave struggled with the ever-increasing demands for spectrum created by continual emergence of new scientific, military, and commercial applications, powered by steady advances in wireless technologies. Development of fundamentally new models and paradigms of spectrum access and management, along with enabling technologies, is needed before it becomes too costly to accommodate new innovations and essential services, or too late to sustain the digital transformation and growth of key industries and public services. This program seeks to develop the intellectual capital enabling the U.S. to smoothly and quickly transition to effective new ways of using and managing the radio and optical spectrum after the end of the current spectrum era of long-term exclusive-use license auctions, thereby sustaining and advancing the social, economic, scientific, and U.S. national leadership benefits derived from the electromagnetic spectrum.

This grant provides funding to strengthen the capacity of the Ministry of Health in Eswatini to effectively respond to HIV, TB, and related public health challenges through technical assistance and the development of sustainable health strategies.

The FY24 LCRP Idea Development Award mechanism promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress toward eradicating deaths and suffering from lung cancer. Research applications only in the area of mesothelioma will not be accepted. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale.New Investigators: The FY24 LCRP Idea Development Award mechanism encourages applications from independent investigators in the early stages of their careers (i.e., within 10 years of their first faculty appointment or equivalent). The New Investigator category is designed to allow applicants early in their faculty appointments to compete for funding separately from established investigators. Applications from New Investigators and Established Investigators will be peer and programmatically reviewed separately. Principal Investigators (PIs) using the New Investigator category are strongly encouraged to strengthen their applications by collaborating with investigators experienced in lung cancer research and/or possessing other relevant expertise. It is the responsibility of the applicant to describe how the included collaboration will augment the PIs expertise to best address the research question. All applicants for the New Investigator category must meet specific eligibility criteria as described in Section II.C, Eligibility Information.Preliminary data to support the feasibility of the research hypotheses and research approaches are required; however, these data do not necessarily need to be derived from studies of lung cancer.Key elements of this award are as follows:Innovation: Research deemed innovative may introduce a new paradigm, challenge current paradigms, look at existing problems from new perspectives, or exhibit other uniquely creative qualities.Impact: Research that has high potential impact may lead to major advancements and significantly accelerate progress toward eradicating deaths and suffering from lung cancer.It is the responsibility of the PI to clearly and explicitly articulate the projects innovation and its potential impact on lung cancer and its relevance to Military Health System (MHS) beneficiaries. The projects impact to both lung cancer research and to patients with lung cancer should be articulated, even if clinical impact is not an immediate outcome. Applications that demonstrate exceptional scientific merit but lack innovation and high potential impact do not meet the intent of the Idea Development Award.

The NIDCD Early Career Research (ECR) Award (R21) supports early-career scientists in conducting basic and clinical research related to hearing, balance, smell, taste, voice, speech, or language, with the goal of generating preliminary data for future R01 grant applications.

Notice of Funding Opportunity SummaryThe Natural Resources Conservation Service (NRCS), an agency under the United States Department of Agriculture (USDA) is announcing potential availability of cooperative agreements for the purpose of leveraging NRCS resources to assist our agency with conducting and implementing important conservation whole farm planning on multiple private landowner properties throughout Southeastern Massachusetts. NRCS recognizes the importance of expanding conservation efforts including irrigation, erosion control, integrated pest management, nutrient management and forestry efforts in Southeastern Massachusetts and the beneficial outcomes it can have on the environment. The agreement holder will also be responsible for providing training to NRCS staff and affiliates as well as customer outreach.NRCS-Massachusetts is making a funding opportunity available for applicants to submit proposals with an award ceiling of $400,000 and a minimum project award of $200,000. NRCS will be awarding a cooperative agreement for up to a five-year period. If, in coordination with NRCS, additional resources are needed at a rate that exceeds this schedule, NRCS may add funds to this agreement to support continued partnership over the performance period.The primary goal is to expand conservation planning to NRCS customers throughout Southeastern Massachusetts. The project list ranges in size from less than 1-acre farms to several hundred-acre farms. Applicants will identify the average number of conservation site visits and written whole farm conservation plans that they could complete in any year with a minimum of fifteen per year being acceptable for this agreement. NRCS will work with the selected applicant to make the choice of priority conservation site visits each year of the agreement based on interest and need. Applicants will be required to hold 1-2 conservation focused trainings per year for NRCS staff and partners to expand their technical knowledge. Applicants should provide a list of training ideas to NRCS for the length of the agreement. Applicants will be awarded based on the specified scoring criteria in Section E of this announcement. Eligible applicants include: all domestic applicants. Neither foreign entities nor individuals are eligible to apply for this opportunity. Applicants should be familiar with all applicable state, federal, local laws, policies, and regulations that apply to conservation improvements in the locales of Massachusetts.For new users of Grants.gov, see Section D. of the full Notice of Funding Opportunity for information about steps required before submitting an application via Grants.gov.Key DatesApplicants must submit their applications via Grants.gov by 11:59 pm Eastern Time on June 29, 2024. For technical issues with Grants.gov, contact Grants.gov Applicant Support at 1-800-518-4726 or support@grants.gov. Awarding agency staff cannot support applicants regarding Grants.gov accounts.For inquiries specific to the content of the NFO requirements, contact the federal awarding agency contact (section G of this NFO). Please limit questions to those regarding specific information contained in this NFO (such as dates, page numbers, clarification of discrepancies, etc.). Questions related to eligibility, or the merits of a specific proposal will not be addressed.The agency anticipates making selections by June 30, 2024, and expects to execute awards by August 15, 2024. These dates are estimates and are subject to change.

This funding opportunity is designed to support research projects that explore how social factors affect cancer care and outcomes for individuals living with HIV, aiming to reduce health disparities in this population.

The "Notice of Intent to Issue Fiscal Year 2025 Solar Module and Solar Hardware (SMASH) Incubator Notice of Funding Opportunity" grant aims to boost private investment in the commercialization of innovative solar photovoltaic technology, focusing on crystalline silicon and cadmium telluride module technologies, and non-module hardware technology, with funding primarily awarded to for-profit entities.

07 March 2024 Update: Please see instructions for full proposal instructions and general submission instructions within the attached documents to this announcement.****CURRENTLY ACCEPTING WHITE PAPER SUBMISSIONS ONLY - DEADLINE FOR WHITE PAPER SUBMISSIONS is 12 DEC 2023*********The pre-proposal (a.k.a. white paper) form and submission instructions is available at the hyperlink below:https://www.acq.osd.mil/eie/afpmb/docs/dwfp/FY24_DWFP_Form.pdf.Applicants should follow the instructions in the pre-proposal form to complete both the form and a separate project summary slide (quad chart). The pre-proposal form and quad chart are submitted as two separate files and also as one combined file, for a total of 3 PDF files. Submissions are due to the AFPMB Webmaster no later than December 12, 2023 (11:59pm EDT). Late submissions will not be considered.Full details are available at related documents tab see downloadable PDF file entitled "BAA Version 1 dated 19 Oct 2023". Note: This document references 3 pages for a white paper/preproposal submission however this should instead reference 3 PDF files make up a preproposal/white paper submission.The U. S. Army Contracting Command, Aberdeen Proving Ground Edgewood Contracting Division, Fort Detrick, invites applications for funding opportunities for the Fiscal Year 2024 Deployed War Fighter Protection (DWFP) Research Program, renewable for up to 3 years, administered by the Armed Forces Pest Management Board (AFPMB). The AFPMB is soliciting pre-proposals for original, innovative research designed to develop new interventions to protect deployed U. S. Department of Defense (DoD) personnel from medically relevant pests, including arthropod disease vectors of mosquito-borne arboviruses and tick-borne pathogens, as well as fly-borne bacterial pathogens. The DWFP Program supports the development of: new toxicants or the adaptation of existing toxicants to medically relevant pests; new insecticide application techniques; new personal protection tools that prevent human-vector contact; new decision support tools; and new vector surveillance tools that focus on improving vector control outcomes. The proposed research should: support the Advanced Technology Development of new insecticides, or improved formulations of existing insecticides for vector control, new technology or enhanced modalities of personal protection from biting arthropods, or improved efficacy and sustainability of equipment for application of pesticides (for more information, see Budget Activity 3 in the DoD Financial Management Regulation Volume 2B, Chapter 5); be product-oriented, consisting of advanced research related to a particular technology or new capability, field evaluation of products, or research directed towards the development of an existing prototype product for commercialization; include semi-field or field evaluation of prototype products; be applicable for both military and civilian uses, including military operational environments with limited logistical support; focus on multiple target vectors; and outline a strategy for subsequent registration by the U. S. Environmental Protection Agency (EPA) for the development of products containing a pesticide(s).The program does not support: basic research; vector pathogen research; clinical, diagnostic, therapeutic or vaccine research in humans; testing to measure acute oral, dermal and/or inhalation toxicity; EPA registration costs; testing and evaluation of products previously registered with the EPA, unless they are being developed for a new use; testing and evaluation of commercial products, unless they are tested in comparison with prototype products; or manufacturing, packaging and production costs.Up to $4,500,000 may be awarded in FY24, with future years subject to the availability of funds. The total proposed cost cannot exceed $975,000, i.e. a maximum of $325,000 per year for up to 3 years, inclusive of all direct and indirect costs. Funding is intended to be provided during August-October 2024. Projects will be selected on the basis of peer-reviewed scientific merit and programmatic relevance. Pre-proposals will be accepted from investigators who are employed by or affiliated with an eligible institution. Eligible institutions include for-profit, non-profit, public, and private organizations. Examples include universities, hospitals, laboratories, companies, and agencies of local, state government. Federal Agencies may also respond to this request; however, federal submissions will be processed in accordance with applicable regulations. Funding for federal agencies is provided subject to an appropriate interagency agreement.The estimated timeline for the FY24 DWFP Program is as follows: December 12, 2023 Deadline for pre-proposal submissions Mid-January 2024 Invitation to submit full proposals Mid-March 2024 Deadline for full proposal submissions Late April/early May 2024 Notification of full proposal selections August/September 2024 Awards funded

This funding opportunity supports the establishment of a central hub to enhance collaboration and research on aging and Alzheimer's disease among various research centers, aimed at improving health outcomes and addressing disparities in these areas.

Notice of Funding Opportunity SummaryThe Natural Resources Conservation Service (NRCS), an agency under the United States Department of Agriculture (USDA) is announcing potential availability of cooperative agreements for the purpose of leveraging NRCS resources to assist our agency with conducting important integrated pest management (IPM) evaluations on multiple private landowner properties throughout Massachusetts. NRCS recognizes the importance of increasing the use of IPM practices on cropland including orchards and on areas privately managed for shellfish aquaculture production. IPM has been an underutilized practice in Massachusetts This agreement will be used to provide training on IPM for NRCS staff and affiliates while also providing needed technical assistance for NRCS customers with IPM site visits.NRCS-Massachusetts is making a funding opportunity available for applicants to submit proposals with an award ceiling of $400,000 and a minimum project award of $200,000. NRCS will be awarding a cooperative agreement for up to a five-year period. If, in coordination with NRCS, additional resources are needed at a rate that exceeds this schedule, NRCS may add funds to this agreement to support continued partnership over the performance period.The primary goal is to expand IPM to NRCS customers throughout Massachusetts. The project list ranges in size from 1-acre farms to several hundred-acre farms. Applicants will identify the average number of IPM site visits and written IPM plans that they could complete in any contract year with a minimum of ten per year being acceptable for this agreement. NRCS will work with the selected applicant to make the choice of priority IPM site visits each year of the agreement based on interest and need. Applicants will be required to hold 1-2 IPM trainings per year for NRCS staff and partners to expand their knowledge on the subject. Applicants should provide a list of training ideas to NRCS for the length of the agreement. Applicants will be awarded based on the specified scoring criteria in Section E of this announcement. Eligible applicants include: all domestic applicants. Applicants should be familiar with all applicable state, federal, local laws, policies, and regulations that apply to IPM in the locales of Massachusetts.For new users of Grants.gov, see Section D. of the full Notice of Funding Opportunity for information about steps required before submitting an application via Grants.gov.Key DatesApplicants must submit their applications via Grants.gov by 11:59 pm Eastern Time on June 29, 2024. For technical issues with Grants.gov, contact Grants.gov Applicant Support at 1-800-518-4726 or support@grants.gov. Awarding agency staff cannot support applicants regarding Grants.gov accounts.For inquiries specific to the content of the NFO requirements, contact the federal awarding agency contact (section G of this NFO). Please limit questions to those regarding specific information contained in this NFO (such as dates, page numbers, clarification of discrepancies, etc.). Questions related to eligibility, or the merits of a specific proposal will not be addressed.The agency anticipates making selections by June 30, 2024, and expects to execute awards by August 15, 2024. These dates are estimates and are subject to change.

This grant provides funding to research institutions for collaborative clinical trials focused on innovative prostate cancer treatments, particularly targeting high-risk populations, including military personnel and veterans.

This funding opportunity supports small businesses in developing innovative tools and devices to improve the care and management of animals used in research, enhancing their welfare and the efficiency of research facilities.

This grant provides funding for research projects that investigate how social factors like race, income, and sexual orientation intersect to affect health disparities in U.S. populations, aiming to inform effective interventions and policies.

The FY24 PRMRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of a disease or condition addressed in one of the congressionally directed FY24 PRMRP Topic Areas and FY24 PRMRP Strategic Goals. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first in human, phase 0) to demonstrate the feasibility or inform the design of more advanced trials through large-scale phase 1 to phase 3 trials to determine efficacy in relevant patient populations.Applications from investigators within the military Services and applications involving multidisciplinary collaborations among academia, industry, the military Services, the U.S. Department of Veterans Affairs (VA), and other federal government agencies are highly encouraged. These relationships can leverage knowledge, infrastructure, and access to unique clinical populations that the collaborators bring to the research effort, ultimately advancing research that is of significance to Service Members, Veterans, and their Families. If the proposed research relies on access to unique resources or databases, the application must describe the access at the time of submission and include a plan for maintaining access as needed throughout the proposed research.CDMRP encourages research on health areas and conditions that affect women uniquely, disproportionately, or differently from men, including studies analyzing sex as a biological variable. Such research should relate anticipated project findings to improvements in women's health outcomes and/or advancing knowledge for women's health.Funding from this award mechanism must support a clinical trial. A clinical trial is defined in the Code of Federal Regulations, Title 45, Part 46.102 (45 CFR 46.102) as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include a placebo or another control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes. Studies that do not seek to measure safety, effectiveness, and/or efficacy outcome(s) of an intervention are not considered clinical trials.

This funding opportunity is designed for researchers and teams focused on improving our understanding of snow accumulation and ice flow dynamics in glaciers across the Northern Hemisphere, with an emphasis on airborne and ground-based observations, modeling, and data synthesis.

This funding opportunity is designed to support research institutions and organizations in developing innovative energetic materials and methods to enhance the Army's capabilities in weapon systems and multi-domain operations.

This funding opportunity supports small businesses in developing innovative medical products to help treat and diagnose individuals struggling with opioid and stimulant use disorders.

This grant provides funding for researchers to develop and validate innovative organ-on-a-chip technologies that model dental, oral, and craniofacial diseases, aiming to improve drug testing and reduce reliance on animal models.

The purpose of this Funding Opportunity Announcement (FOA) is to facilitate the transition of previously funded SBIR and STTR Phase II and Phase IIB projects in pain management to the commercialization stage by providing additional assistance for private partnering activities through the Commercialization Readiness Pilot (CRP) program. Specifically, this FOA supports the addition of entrepreneurial expertise into small business leadership teams along with supporting partnering activities to aid in commercialization through private third-party funding or partnership with industry.